The State of Clinical Trials in the U.K. and Europe
State of Digital Clinical Trials Podcast
00:00
Revitalizing UK Clinical Trials
This chapter explores the decline of new clinical trial initiations in the UK from 2017 to 2021, exacerbated by Brexit and COVID-19. It highlights the government's commitment to rejuvenating the life sciences sector through significant investment, regulatory reforms, and streamlined processes. The discussion emphasizes the necessity of effectively leveraging the UK's structural advantages to regain its status as a prime location for clinical research.
Transcript
Play full episode
